References
- Eschbach J W. The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin. Kidney Int 1989; 35: 134–148
- Eschbach J W., Ergie J, Downing M, Browne J K., Adamson J W. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 1987; 316: 73–78
- Sinai-Treiman L, Salusky I B., Fine R N. Use of subcutaneous recombinant human erythropoietin in children undergoing continuous cycling peritoneal dialysis. J Pediatr 1989; 114: 550–554
- Wallner S F., Vautrin R M. Evidence that inhibition of erythropoiesis is important in the anemia of chronic renal failure. J Lab Clin Med 1981; 97: 170–178
- Ganser A, Bergmann M, Volkers B, Grutzmacher P, Scigalla P, Hoelzer D. In vivo effects of recombinant human erythropoietin on circulating human hernopoietic progenitor cells. Exp Hematol 1989; 17: 433–435
- Dukes P P., Ma A, Clernons G K., Meytes D. Measurement of erythroid burst-promoting activity by a specific cell culture assay. Exp Hematol 1985; 13: 59–64
- Hahn T, Barak Y, Leibovitch E, Malach L, Dagan O, Rubinstein E. Ciprofloxacin inhibits human haematopoietic cell growth: synergism with tumor necrosis factor and interferon. Exp Hematol 1991; 19: 157–159
- Eschbach J W., Haley N R., Egrie J C., Adamson J W. A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects. Kidney Int 1992; 42: 407–416
- Nicolis S, Ottolenghi S, Papayannopoulou T, et al. Dependence for the proliferative response to erythropoietin on an established erythroid differentiation program in a human haematopoietic cell line, UT-7. Exp Hematol 1993; 21: 665–670
- Koenig J M., Christensen R D. Effect of erythropoietin on granulopoiesis: in vitro and in vivo studies in weanling rats. Pediatr Res 1990; 27: 583–587